Cargando…

Acute Stroke Biomarkers: Are We There Yet?

Background: Distinguishing between stroke subtypes and knowing the time of stroke onset are critical in clinical practice. Thrombolysis and thrombectomy are very effective treatments in selected patients with acute ischemic stroke. Neuroimaging helps decide who should be treated and how they should...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dagonnier, Marie, Donnan, Geoffrey A., Davis, Stephen M., Dewey, Helen M., Howells, David W.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Neurology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7902038/ https://www.ncbi.nlm.nih.gov/pubmed/33633673 http://dx.doi.org/10.3389/fneur.2021.619721

Ejemplares similares

Discovery and Longitudinal Evaluation of Candidate Biomarkers for Ischaemic Stroke by Mass Spectrometry-Based Proteomics
por: Dagonnier, Marie, et al.
Publicado: (2017)

Cell-Based Therapies for Stroke: Are We There Yet?
por: Krause, Mirja, et al.
Publicado: (2019)

Patterns of Infarction on MRI in Patients With Acute Ischemic Stroke and Cardio-Embolism: A Systematic Review and Meta-Analysis
por: Sharobeam, Angelos, et al.
Publicado: (2020)

Longitudinal Stroke Recovery Associated With Dysregulation of Complement System—A Proteomics Pathway Analysis
por: Nguyen, Vinh A., et al.
Publicado: (2020)

Hyperacute changes in blood mRNA expression profiles of rats after middle cerebral artery occlusion: Towards a stroke time signature
por: Dagonnier, Marie, et al.
Publicado: (2018)

Googling Boundaries for Operating Mobile Stroke Unit for Stroke Codes
por: Phan, Thanh G., et al.
Publicado: (2019)

Improving Technology to Diagnose Tuberculous Meningitis: Are We There Yet?
por: Ssebambulidde, Kenneth, et al.
Publicado: (2022)

Biomarkers for SUDEP: Are We There Yet?
por: King-Stephens, David
Publicado: (2019)

Mobilization after thrombolysis (rtPA) within 24 hours of acute stroke: what factors influence inclusion of patients in A Very Early Rehabilitation Trial (AVERT)?
por: Muhl, Linnéa, et al.
Publicado: (2014)

A Rare, Unreported Cognitive Side Effect of Topiramate: Do We Know It All Yet?
por: Karim, Nurose, et al.
Publicado: (2020)

Editorial: Blood-Based Biomarkers in Acute Ischemic Stroke and Hemorrhagic Stroke
por: Uphaus, Timo, et al.
Publicado: (2022)

Biomarkers in Alzheimer disease: are we there yet?
por: Generoso, Jaqueline S., et al.
Publicado: (2020)

Family physician decisions following stroke symptom onset and delay times to ambulance call
por: Mosley, Ian, et al.
Publicado: (2011)

Expression of Cytokines and Chemokines as Predictors of Stroke Outcomes in Acute Ischemic Stroke
por: Martha, Sarah R., et al.
Publicado: (2020)

Neurodegeneration Over 3 Years Following Ischaemic Stroke: Findings From the Cognition and Neocortical Volume After Stroke Study
por: Brodtmann, Amy, et al.
Publicado: (2021)

Tenecteplase versus Alteplase for Stroke Thrombolysis Evaluation Trial in the Ambulance (Mobile Stroke Unit—TASTE-A): protocol for a prospective randomised, open-label, blinded endpoint, phase II superiority trial of tenecteplase versus alteplase for ischaemic stroke patients presenting within 4.5 hours of symptom onset to the mobile stroke unit
por: Bivard, Andrew, et al.
Publicado: (2022)

Are we nearly there yet?
por: Battersby, Stephen
Publicado: (2005)

Imaging Acute Stroke: From One-Size-Fit-All to Biomarkers
por: Lu, Jianfei, et al.
Publicado: (2021)

Biomarkers in renal cell carcinoma: Are we there yet?
por: Gulati, Shuchi, et al.
Publicado: (2021)

Economic Evaluation Protocol and Statistical Analysis Plan for the Cost-Effectiveness of a Novel Australian Stroke Telemedicine Program; the Victorian Stroke Telemedicine (VST) program
por: Cadilhac, Dominique A., et al.
Publicado: (2021)

Telemedicine for Stroke: Quantifying the Long-Term National Costs and Health Benefits
por: Gao, Lan, et al.
Publicado: (2022)

Where Will the Next Generation of Stroke Treatments Come From?
por: Howells, D. W., et al.
Publicado: (2010)

Biomarkers for Antiplatelet Therapies in Acute Ischemic Stroke: A Clinical Review
por: Alhazzani, Adel, et al.
Publicado: (2021)

Leukocyte Biomarkers for the Differential Diagnosis of Mild Acute Ischemic Stroke, Transient Ischemic Attack, and Stroke Mimic
por: Cavrak, Megan E, et al.
Publicado: (2021)

High Actin Expression in Thrombus of Acute Ischemic Stroke Can Be a Biomarker of Atherothrombotic Origin Stroke
por: Wang, Rongyu, et al.
Publicado: (2022)

Are we there yet?
por: Wise, Jo Ann
Publicado: (2015)

Are we there yet?
por: Swann, Nicole
Publicado: (2019)

Are we there yet?
por: McCann, Shaun R.
Publicado: (2022)

Rehabilitation: a key service, yet highly underused, in the management of young patients with sickle cell disease after stroke in DR of Congo
por: Boma, Paul Muteb, et al.
Publicado: (2023)

Identification of immune-related biomarkers co-occurring in acute ischemic stroke and acute myocardial infarction
por: Wang, Shan, et al.
Publicado: (2023)

Neurological manifestations of post-acute sequelae of COVID-19: which liquid biomarker should we use?
por: Comeau, Dominique, et al.
Publicado: (2023)

Regenerative medicine: are we there yet?
por: Badylak, Stephen, et al.
Publicado: (2017)

DNA methylation biomarkers in asthma and rhinitis: Are we there yet?
por: Legaki, Evangelia, et al.
Publicado: (2022)

The role of neuroimaging in acute stroke
por: Dhamija, Rajinder K., et al.
Publicado: (2008)

Editorial: Biomarkers for stroke recovery
por: Kumar, Pradeep, et al.
Publicado: (2023)

S100b in acute ischemic stroke clots is a biomarker for post-thrombectomy intracranial hemorrhages
por: Rossi, Rosanna, et al.
Publicado: (2023)

Recovery Potential After Acute Stroke
por: Seitz, Rüdiger J., et al.
Publicado: (2015)

Atypical Autoimmune Encephalitis With Neuropil Antibodies Against a Yet Unknown Epitope
por: Edwin Thanarajah, Sharmili, et al.
Publicado: (2019)

One-Year Risk of Stroke After Transient Ischemic Attack or Minor Stroke in Hunter New England, Australia (INSIST Study)
por: Tomari, Shinya, et al.
Publicado: (2021)

Neutrophil-to-Lymphocyte Ratio as a Predictive Biomarker for Stroke Severity and Short-Term Prognosis in Acute Ischemic Stroke With Intracranial Atherosclerotic Stenosis
por: Ying, Yuanlin, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_lk3o2dnlksd6bg3aihe8p52svr